This live session has now concluded, please return to Moneycontrol for more updates.
Coronavirus India News Live Updates: An increase by few a thousand new Covid-19 cases was seen in the country in the last 24 hours with 2,67,334 more people testing positive, said the Union health ministry on Wednesday. The number stood at 2,63,533 on Tuesday. With the addition of fresh infections, the cumulative caseload in the country has reached 2,54,96,330. India's daily spike has remained below 3 lakh for the third consecutive day. However, the death toll has seen a huge
Mumbai receives bids to import 10 million Sputnik jabs at Rs 700 crore: Report
EU agrees to reopen borders to fully vaccinated travellers: Sources
Rajasthan government declares Black Fungus an epidemic
Coronavirus LIVE Updates | 3 lessons the COVID-19 pandemic can teach us about preventing chronic diseases
Forty-four per cent of Canadian adults live with at least one chronic health condition such as heart disease, diabetes or a mood disorder. Up to 80 per cent of these conditions can be prevented. However, chronic disease prevention and health promotion are not taken seriously enough. Instead, Canadian health care is focused on treating acute and chronic conditions. As a result, the treatment of chronic diseases costs our health-care system $68 billion per year and overburdens health-care providers.
While the pandemic has focused the world’s attention on how to prevent infectious disease, many of the lessons learned from COVID-19 prevention can also be applied to chronic disease prevention. We — a scientist who develops health behaviour-change interventions, and a family doctor who is passionate about preventive medicine — have noted several pandemic lessons that could be used to improve chronic disease prevention. Here are three:
Address the inequities
COVID-19 infections are not evenly distributed among Canadians. Infection rates are higher in regions with greater proportions of low-income and Black residents. Likewise, health iniquities mean that racialized and Indigenous people, immigrants, people with disabilities and those affected by poverty are at increased risk for developing chronic diseases. These groups may not have equitable access to preventive resources such as healthy foods, a family doctor, health screening and health promotion programmes. In addition, the stress caused by poverty, trauma and discrimination can affect the body, increasing the likelihood of developing a chronic disease.
COVID-19 has exposed long-standing health inequities. In response, we’ve seen community groups, public health agencies and governments work together to provide free masks, community testing sites, vaccines, and other services in low-income and racialized communities. Health inequities that increase the risk for chronic disease could be eliminated by continuing to provide these types of services to the people most in need.
A one-size-fits-all approach doesn’t work
Physical distancing can work to reduce the risk of COVID-19, but is impossible if you live in a multi-generational household, use public transportation or have a disability and rely on caregivers. From masks to physical distancing to physical barriers, different types of protection are needed to reduce the risk of COVID-19 spread for people in different circumstances. Even better is when communities are engaged and empowered to develop their own culturally appropriate advice and messages.
Likewise, chronic disease prevention programs must be tailored to take into account a community’s needs and priorities. This is best accomplished by designing programs and policies in partnership with the communities who will use them. Community involvement helps ensure programs are tailored to community members’ needs and that users will benefit.
For instance, researchers from the University of British Columbia Centre for Chronic Disease Prevention and Management worked with nearly 300 community members to design a physical activity program specifically for people with disabilities. Over six months, program participants increased their weekly physical activity by 363 per cent and significantly improved their heart and lung health. The program would not have been so successful had community members not helped to tailor the program to the unique challenges and needs of people with disabilities. We can (and must) get research into practice faster
The pandemic has shown that science can be drastically accelerated to move innovations quickly from the lab to the community to individual citizens. The pandemic prompted many researchers to pause their own projects and collaborate worldwide to detect and identify the virus, study its transmission and create and test vaccines. Funding was allocated to facilitate research collaborations.
These actions sped up the research process. The findings were then quickly translated into public health advice, guidelines for medical care and vaccines that have been shared and used around the world. Research can guide which evidence-based chronic disease prevention programs are put into practice. However, the translation of health research evidence into practice is notoriously slow.
A frequently cited study estimated that it takes 17 years to put just a fraction of health research into practice. One reason for this delay is that the scientists who develop and test chronic disease prevention programs, and the community, health-care and government organisations who deliver programs, typically do not work together. The pandemic has changed the culture of science. We have seen the benefits when scientists collaborate across disciplines, and industry and government partners are at the ready to quickly move new discoveries into practice.
If we approached chronic disease prevention with the same urgency, promising evidence-based interventions could be quickly scaled up and delivered in communities across the country. Applying the lessons of COVID-19 to chronic disease prevention has the potential to benefit millions of Canadians and save billions in health-care costs. The response to the COVID-19 pandemic has proven that focused attention and collaborative efforts can yield effective results in disease prevention and treatment.
Nepal, Bangladesh scramble to secure COVID-19 shots as India curbs exports
5.86 crore COVID vaccine doses to be provided for free to states, UTs from May 1 to June 15, says govt
Special task force will be formed to protect children from third COVID wave, says Arvind Kejriwal
Telangana floats global tender for 10 million COVID-19 vaccine doses
Hospital beds free up as COVID-19 cases see steady decline in Delhi
Covaxin, Sputnik V to be manufactured in Karnataka soon
Deferring vaccination for six months after COVID recovery a threat, says IMA chief
Eligible population in Karnataka to be vaccinated against COVID-19 by 2021 end: Minister
Deaths due to COVID-19 increasing, vaccines reducing, says Rahul Gandhi
Over 1,300 O2 beds, about 530 ICU beds added in 12 AIIMS for COVID treatment
Delhi HC refuses to stay clinical trial of Covaxin for 2-18 age group
AstraZeneca vaccine followed by Pfizer dose is 'highly safe, effective': Study
India logs 13% fall in new COVID-19 cases in week; still highest globally, says WHO
COVID lockdown extension in Maharashtra? Here's what Aaditya Thackeray has to say
From June, govt expects deaths to come down, COVID-19 vaccination numbers to go up
More pharma firms should be allowed to make COVID-19 vaccine in India, says Nitin Gadkari
Odisha lockdown extended until June 1
Record 4,529 fatalities in single day in India
India's Biological E. to produce Johnson & Johnson COVID-19 vaccine
Maharashtra must aim to produce 3,000 MT medical oxygen per day: CM Uddhav Thackeray
Delhi receives over 60,000 Covaxin doses for 45-plus, key workers: AAP MLA Atishi
Never exported vaccines at the cost of the people of India, says Serum Institute's Adar Poonawalla
COVID lockdown extension in Maharashtra? Here's what Aaditya Thackeray has to say
Singapore rejects Delhi CM Arvind Kejriwal's tweet on 'very dangerous' COVID-19 strain in the country
India reports over 4,500 fatalities, highest-ever in 24 hours
Govt may include oxygen concentrators, delivery-related equipment in PLI scheme: Report
13.2 lakh people receive jab on May 18, over 18.5 crore shots administered in India so far
Sudan bans travellers from India, imposes other COVID-19 restrictions
US Congressman praises PM Modi's efforts during COVID crisis
American vaccines effective against COVID strain first found in India: US officials
Microsoft provides 125 oxygen concentrators to Noida Authority
Tamil Nadu to commence vaccination of people in 18-44 age group on May 20: Minister
Tamil Nadu, Punjab, Assam may see peak in COVID cases in next 2 weeks: SUTRA model
Maharashtra reports 28,438 new COVID19 cases, 52,898 discharges and 679 deaths in the last 24 hours
West Bengal reports 19,428 new COVID19 cases, 19,050 recoveries and 145 deaths in the last 24 hours
Mumbai records 953 new COVID19 cases, 2,258 recoveries and 44 deaths in the last 24 hours
Punjab registers 7,143 fresh COVID19 cases, 231 fatalities and 8,174 discharges in the last 24 hours
This live session has now concluded, please return to Moneycontrol for more updates.
The cumulative number of COVID-19 vaccine doses administered in the country stands at 18,69,89,265 as per the 8 pm provisional report today. 5,27,067 beneficiaries of the age group 18-44 years received their first dose of COVID vaccine today and cumulatively 70,12,752 across 36 States/UTs since the start of Phase-3 of the vaccination drive.
The government has taken extraordinary steps to ramp up the production of O2 and transport. It was the hard work of lot of people that we were able to deal with the peak. The second wave took us by surprise, but we have responded very well. Now the supply-demand situation is much better, saysNITI Ayog Vice Chairman Rajiv Kumar.
Dr Reddy’s releases important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories
The number of recoveries continued to outnumber fresh COVID-19 cases in Karnataka,as the state on Wednesday reported 49,953 discharges, 34,281 newcases and 468 fatalities, the Health Department said.
Maharashtra reports 34,031 new COVID-19 cases, 51,457 recoveries and 594 deaths in the last 24 hours
Total cases 54,67,537
Total recoveries 49,78,937 (recovery rate 91.06%)
Death toll 84,371
Active cases 4,01,695
as per state government records.
Uttarakhand reports 4492 new COVID-19 cases, 7333 recoveries and 110 deaths in the last 24 hours; active cases at 73,172 as per state government records.
elangana registers 3837 new COVID-19 cases, 4976 recoveries and 25 fatalities today
Total cases 5,40,603
Total recoveries 4,90,620
Death toll 3037
as per state government records.
Mumbai records 1350 new COVID-19 cases, 4565 recoveries and 57 deaths in the last 24 hours
Active cases 29,643
Total cases 6,92,239
Death toll 14,409
Total recovered cases 6,46,163
as per state government records.
5,065 new COVID-19 cases, 88 deaths and 10,337 recoveries reported in Madhya Pradesh today.
Total cases 7,47,783
Death toll 7,227
Total recoveries 6,62,949
Active cases 77,607
as per state government records.
42 patients of Mucormycosis (black fungus) have been reported in AIIMS Rishikesh so far, including 2 patients who died & one discharges after treatment. Out of 39 patients undergoing treatment, 26 have undergone surgery: Harish Thapliyal, PRO, AIIMS- Rishikesh (ANI)
